$ACHV
ACHIEVE LIFE SCIENCES, INC.

2014 Q2 Form 10-Q Financial Statement

#000119312514172143 Filed on April 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $4.930M $11.73M $5.080M
YoY Change -22.24% 130.91% 284.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.680M $2.760M $2.500M
YoY Change 8.5% 10.4% 43.68%
% of Gross Profit
Research & Development $9.883M $16.90M $10.86M
YoY Change -25.48% 55.72% 113.6%
% of Gross Profit
Depreciation & Amortization $50.00K $55.00K $44.00K
YoY Change -16.67% 25.0% 120.0%
% of Gross Profit
Operating Expenses $9.883M $16.90M $10.86M
YoY Change -25.48% 55.72% 113.6%
Operating Profit
YoY Change
Interest Expense $0.00 $10.00K $50.00K
YoY Change -100.0% -80.0% 0.0%
% of Operating Profit
Other Income/Expense, Net $615.0K -$707.0K $1.582M
YoY Change -36.99% -144.69% -216.58%
Pretax Income -$7.020M -$8.640M -$6.700M
YoY Change -16.63% 28.96% -2.33%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.015M -$8.636M -$6.697M
YoY Change -16.69% 28.95% -2.38%
Net Earnings / Revenue -142.29% -73.62% -131.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$702.0M -$864.0M -$670.0M
COMMON SHARES
Basic Shares Outstanding 14.75M shares 14.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.60M $37.60M $64.60M
YoY Change -28.77% -41.8% -41.96%
Cash & Equivalents $40.61M $28.63M $18.63M
Short-Term Investments $0.00 $8.900M $46.00M
Other Short-Term Assets $2.300M $1.800M $3.400M
YoY Change -34.29% -47.06% 36.0%
Inventory
Prepaid Expenses
Receivables $4.951M $8.610M $5.200M
Other Receivables $0.00 $200.0K $300.0K
Total Short-Term Assets $47.85M $48.15M $73.50M
YoY Change -28.9% -34.49% -35.86%
LONG-TERM ASSETS
Property, Plant & Equipment $354.0K $349.0K $400.0K
YoY Change -29.2% -12.75% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.274M $1.075M $1.500M
YoY Change -15.07% -28.33% 200.0%
Total Long-Term Assets $1.879M $1.675M $1.900M
YoY Change -6.05% -11.84% 216.67%
TOTAL ASSETS
Total Short-Term Assets $47.85M $48.15M $73.50M
Total Long-Term Assets $1.879M $1.675M $1.900M
Total Assets $49.73M $49.82M $75.40M
YoY Change -28.24% -33.92% -34.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.341M $923.0K $7.900M
YoY Change 1241.0% -88.32% 172.41%
Accrued Expenses $13.25M $13.04M
YoY Change 27.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.100M $1.100M $1.100M
YoY Change 0.0% 0.0% -21.43%
Total Short-Term Liabilities $20.17M $16.90M $11.00M
YoY Change 58.83% 53.64% -64.52%
LONG-TERM LIABILITIES
Long-Term Debt $3.100M $3.300M $4.100M
YoY Change -20.51% -19.51% -32.79%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.100M $3.300M $4.100M
YoY Change -20.51% -19.51% -32.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.17M $16.90M $11.00M
Total Long-Term Liabilities $3.100M $3.300M $4.100M
Total Liabilities $23.27M $20.22M $15.10M
YoY Change 40.16% 33.91% -59.3%
SHAREHOLDERS EQUITY
Retained Earnings -$149.3M -$142.3M
YoY Change
Common Stock $173.2M $169.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.47M $29.60M $60.30M
YoY Change
Total Liabilities & Shareholders Equity $49.73M $49.82M $75.40M
YoY Change -28.24% -33.92% -34.55%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$7.015M -$8.636M -$6.697M
YoY Change -16.69% 28.95% -2.38%
Depreciation, Depletion And Amortization $50.00K $55.00K $44.00K
YoY Change -16.67% 25.0% 120.0%
Cash From Operating Activities -$2.910M -$1.690M -$10.69M
YoY Change -61.04% -84.19% 44.85%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K $7.000K $110.0K
YoY Change -50.0% -93.64%
Acquisitions
YoY Change
Other Investing Activities $8.920M $15.71M $11.35M
YoY Change 15.54% 38.41% -162.85%
Cash From Investing Activities $8.860M $15.70M $11.24M
YoY Change 16.58% 39.68% -162.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.030M 30.00K 10.00K
YoY Change 200.0% -99.98%
NET CHANGE
Cash From Operating Activities -2.910M -1.690M -10.69M
Cash From Investing Activities 8.860M 15.70M 11.24M
Cash From Financing Activities 6.030M 30.00K 10.00K
Net Change In Cash 11.98M 14.04M 560.0K
YoY Change 9115.38% 2407.14% -98.02%
FREE CASH FLOW
Cash From Operating Activities -$2.910M -$1.690M -$10.69M
Capital Expenditures -$60.00K $7.000K $110.0K
Free Cash Flow -$2.850M -$1.697M -$10.80M
YoY Change -61.22% -84.29% 46.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14753195 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18628000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14753195 shares
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1587301 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14753195 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.47
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1257088 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13041000
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1097000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8000
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
81000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
923000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16900000
CY2014Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
300000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2642000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
904000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1075000
CY2014Q1 us-gaap Short Term Investments
ShortTermInvestments
8922000
CY2014Q1 us-gaap Assets
Assets
49824000
CY2014Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
37803000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28630000
CY2014Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
935000
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3320000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
29604000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
169272000
CY2014Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2014Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
935000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142325000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
15000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49824000
CY2014Q1 us-gaap Liabilities
Liabilities
20220000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
73000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
48149000
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
251000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8610000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1821000
CY2014Q1 us-gaap Cash
Cash
15348000
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4200000
CY2014Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
166000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
349000
CY2014Q1 ogxi Indemnification Expense
IndemnificationExpense
0
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18075000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14707886 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14707886 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.39
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1006991 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11784000
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1092000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
139000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14934000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2643000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1705000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
214000
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3544000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
37211000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
168242000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
214000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133689000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55689000
CY2013Q4 us-gaap Liabilities
Liabilities
18478000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Assets Current
AssetsCurrent
53867000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
314000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1111000
CY2013Q4 us-gaap Assets
Assets
55689000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14593000
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
24629000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8657000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5770000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2700000
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
218000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
397000
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0112 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.88 pure
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14660643 shares
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10691000
CY2013Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
10004 shares
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3100 shares
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-370000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6703000
CY2013Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
11280000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
52000
CY2013Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-6000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4442000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1582000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6697000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
110000
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2013Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1434000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
13355000
CY2013Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-848000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2500000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
748000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
553000
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
11237000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1853000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10855000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000949858
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
19627000
CY2013Q1 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-164000
CY2013Q1 us-gaap Depreciation
Depreciation
44000
CY2013Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3000000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-130000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000
CY2013Q1 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2013Q1 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-3000
CY2013Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
5076000
CY2013Q1 ogxi Property And Equipment Acquired Under Lease Obligation
PropertyAndEquipmentAcquiredUnderLeaseObligation
24000
CY2014Q1 dei Trading Symbol
TradingSymbol
OGXI
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
ONCOGENEX PHARMACEUTICALS, INC.
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0182 pure
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.81 pure
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14721500 shares
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.79
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1692000
CY2014Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
35309 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
260097 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3400000 shares
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3985000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8637000
CY2014Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
51000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000
CY2014Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-52000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-47000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-707000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-8636000
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2014Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
CY2014Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
721000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
721000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
19660000
CY2014Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-801000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2757000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
30000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1000000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14037000
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
15700000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1257000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16903000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000
CY2014Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
15758000
CY2014Q1 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-189000
CY2014Q1 us-gaap Depreciation
Depreciation
55000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
784000
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000
CY2014Q1 ogxi Class Of Warrant Or Right Exercise Price Of Warrant Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantOrRights
20
CY2014Q1 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2014Q1 ogxi Expiration Of Non Cancellable Operating Lease Agreement
ExpirationOfNonCancellableOperatingLeaseAgreement
2017
CY2014Q1 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2014Q1 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
30000
CY2014Q1 ogxi Maximum Maturity Period Of Collateralized Securities
MaximumMaturityPeriodOfCollateralizedSecurities
P1Y
CY2014Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
11731000
CY2014Q1 ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2015-01
CY2014Q1 ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2014Q1 ogxi Class Of Warrant Or Right Expiration Year And Month
ClassOfWarrantOrRightExpirationYearAndMonth
2015-10

Files In Submission

Name View Source Status
0001193125-14-172143-index-headers.html Edgar Link pending
0001193125-14-172143-index.html Edgar Link pending
0001193125-14-172143.txt Edgar Link pending
0001193125-14-172143-xbrl.zip Edgar Link pending
d697509d10q.htm Edgar Link pending
d697509dex311.htm Edgar Link pending
d697509dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ogxi-20140331.xml Edgar Link completed
ogxi-20140331.xsd Edgar Link pending
ogxi-20140331_cal.xml Edgar Link unprocessable
ogxi-20140331_def.xml Edgar Link unprocessable
ogxi-20140331_lab.xml Edgar Link unprocessable
ogxi-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending